Risks Associated With the Non-Medicinal Use of Cannabis

被引:77
|
作者
Hoch, Eva [1 ]
Bonnet, Udo [2 ]
Thomasius, Rainer [3 ]
Ganzer, Florian [3 ]
Havemann-Reinecke, Ursula [4 ,5 ,6 ]
Preuss, Ulrich W. [7 ,8 ]
机构
[1] Heidelberg Univ, Dept Addict Behav & Addict Med, Cent Inst Mental Hlth, D-69115 Heidelberg, Germany
[2] Univ Duisburg Essen, Dept Psychiat Psychotherapy & Psychosomat Med, Evangel Krankenhaus Castrop Rauxel, Teaching Hosp, Essen, Germany
[3] Univ Hosp Hamburg Eppendorf, German Ctr Addict Res Childhood & Adolescence DZS, Hamburg, Germany
[4] Univ Gottingen, Dept Psychiat & Psychotherapy, Fac Med, Gottingen, Germany
[5] Univ Med Ctr Gottingen, DFG Res Ctr, Gottingen, Germany
[6] Univ Med Ctr Gottingen, Cluster Excellence Nanoscale Microscopy & Mol Phy, Gottingen, Germany
[7] Kreiskrankenhaus Prignitz, Dept Psychiat Psychotherapy & Psychosomat Med, Perleberg, Germany
[8] Univ Halle Wittenberg, Dept Psychiat Psychotherapy & Psychosomat Med, D-06108 Halle, Saale, Germany
来源
DEUTSCHES ARZTEBLATT INTERNATIONAL | 2015年 / 112卷 / 16期
关键词
USE DISORDERS; SUICIDAL BEHAVIORS; TREATMENT PROGRAM; BIPOLAR DISORDER; MARIJUANA USE; LUNG-CANCER; WITHDRAWAL; SMOKING; INTERVENTIONS; ABSTINENCE;
D O I
10.3238/arztebl.2015.0271
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cannabis is the most commonly consumed illicit drug around the world; in Germany, about 4.5% of all adults use it each year. Intense cannabis use is associated with health risks. Evidence-based treatments are available for health problems caused by cannabis use. Methods: Selective literature review based on a search of the PubMed database, with special emphasis on systematic reviews, meta-analyses, cohort studies, randomized controlled trials (RCTs), case-control studies, and treatment guidelines. Results: The delta-9-tetrahydrocannabinol content of cannabis products is rising around the world as a result of plant breeding, while cannabidiol, in contrast, is often no longer detectable. Various medical conditions can arise acutely after cannabis use, depending on the user's age, dose, frequency, mode and situation of use, and individual disposition; these include panic attacks, psychotic symptoms, deficient attention, impaired concentration, motor incoordination, and nausea. In particular, intense use of high doses of cannabis over many years, and the initiation of cannabis use in adolescence, can be associated with substance dependence (DSM-5; ICD-10), specific withdrawal symptoms, cognitive impairment, affective disorders, psychosis, anxiety disorders, and physical disease outside the brain (mainly respiratory and cardiovascular conditions). At present, the most effective way to treat cannabis dependence involves a combination of motivational encouragement, cognitive behavioral therapy, and contingency management (level 1a evidence). For adolescents, family therapy is also recommended (level 1a evidence). No pharmacological treatments can be recommended to date, as evidence for their efficacy is lacking. Conclusion: Further research is needed to elucidate the causal relationships between intense cannabis use and potential damage to physical and mental health. Health problems due to cannabis use can be effectively treated.
引用
收藏
页码:271 / +
页数:12
相关论文
共 50 条
  • [41] TCM non-medicinal therapy for regulation and treatment of chronic fatigue syndrome
    Feng Z.
    Pang Y.
    Ye F.-W.
    Journal of Acupuncture and Tuina Science, 2008, 6 (6) : 376 - 380
  • [42] Medicinal Cannabis and Synthetic Cannabinoid Use
    Pichini, Simona
    Lo Faro, Alfredo Fabrizio
    Busardo, Francesco Paolo
    Giorgetti, Raffaele
    MEDICINA-LITHUANIA, 2020, 56 (09):
  • [43] MEDICINAL USE OF CANNABIS: AN INDUSTRY PERSPECTIVE
    Vita, Nicholas
    Mazanet, Rosemary
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2025, 30 (01)
  • [44] Medicinal cannabis use in palliative care
    Herbert, Anthony
    Hardy, Janet
    AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2021, 50 (06) : 363 - 368
  • [45] Medicinal use of cannabis: a review of the evidence
    Rojas-Jara, Claudio
    Polanco-Carrasco, Roberto
    Cisterna, Alejandra
    Hernandez, Vanesa
    Miranda, Fernanda
    Moreno, Andrea
    Alarcon, Luis
    TERAPIA PSICOLOGICA, 2019, 37 (02): : 166 - 180
  • [46] Natural wax from non-medicinal aerial part of Codonopsis pilosula as a biolubricant
    Xie, Min
    Cheng, Jun
    Zhao, Guohu
    Liu, Haixia
    Zhang, Li
    Yang, Cailing
    JOURNAL OF CLEANER PRODUCTION, 2020, 242
  • [47] An Australian nationwide survey on medicinal cannabis use for epilepsy: History of antiepileptic drug treatment predicts medicinal cannabis use
    Suraev, Anastasia S.
    Todd, Lisa
    Bowen, Michael T.
    Allsop, David J.
    McGregor, Lain S.
    Ireland, Carol
    Lintzeris, Nicholas
    EPILEPSY & BEHAVIOR, 2017, 70 : 334 - 340
  • [48] Explainable Machine Learning Elucidates the Affective, Cognitive, and Social Factors Driving Non-Medicinal Opioid Use in Young Adults
    Maxwell, Andrea
    Niklason, Gregory
    Ma, Sisi
    Zilverstand, Anna
    DRUG AND ALCOHOL DEPENDENCE, 2024, 260
  • [49] Medicinal use of cannabis in EuropeThe fact that more countries legalize the medicinal use of cannabis should not become an argument for unfettered and uncontrolled use
    Maurizio Bifulco
    Simona Pisanti
    The EMBO Reports, 2015, 16 (2): : 130 - 132
  • [50] AN INVESTIGATION OF THE ATTITUDES AND AWARENESS OF THE RISKS ASSOCIATED WITH CANNABIS USE IN AN IRISH ADOLESCENT POPULATION
    Barrett, P.
    EUROPEAN PSYCHIATRY, 2012, 27